Tilray shares jumped 4% on record Q3 revenue of $206.7 million, driven by a 73% surge in international cannabis sales. While net loss narrowed to $0.24 per share, it missed analyst estimates. The company reaffirmed its full-year EBITDA outlook of $62-72 million, turning retail sentiment extremely bullish.